Patents by Inventor Michael N. Krupp

Michael N. Krupp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)m ethyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
    Patent number: 4798835
    Abstract: This invention relates of the use of a certain thiazolidine-2,4-dione, namely, dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dio ne, or a pharmaceutically acceptable cationic salt thereof, for retarding the development of arterial disease in mammals. More specifically, it relates to a method for reducing the serum cholesterol levels in mammals by administering to said mammals dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]-thiazolidine-2,4-di one or a pharmaceutically acceptable cationic salt thereof.
    Type: Grant
    Filed: December 2, 1987
    Date of Patent: January 17, 1989
    Assignee: Pfizer Inc.
    Inventors: Michael N. Krupp, Archie C. Swindell